About Dr. Allen A. Herman, Chief Medical Officer o
Post# of 306
Posted On: 05/23/2016 11:49:30 AM
About Dr. Allen A. Herman, Chief Medical Officer of CBIS. GLTA
From a pr. in March of 2015 :
Dr. Herman, while serving as a project officer and program director at the National Institutes of Health (NIH) designed the basis for a nationwide $160 million infant mortality reduction program and was the co-director of joint projects between the NIH and the Centers for Disease Control and Prevention (CDC). His work as the scientific director of a $25 million NIH Infant Mortality Reduction research program defined much of the basis for much of the current community-based maternal and child health public health work designed to provide a healthy start for families. For his work in maternal and child health Dr. Herman received the National Institutes Award of Merit. In addition to his work on maternal and child health, Dr. Herman was a member of the World Mental Health Survey team and helped design and execute the South African Stress and Health Study, the largest mental health survey in Africa.
He was the founding Dean of the Republic of South Africa's National School of Public Health. Dr. Herman also served as scientific advisor to then deputy-president (and now president) of the Republic of South Africa, Jacob Zuma and the South African Minister of Defense in the design and execution of a substantial HIV/AIDS treatment program for the South African National Defense Force. Dr. Herman and Mr. Dellums secured $100 million from Bristol-Myers Squibb. These funds were used to develop the 'Secure the Future' project, a research and scientific development program in southern Africa. Dr. Herman served as a Principal Investigator and on the Scientific Advisory Board of 'Secure the Future'.
Dr. Herman was also the Advisor to Ronald V. Dellums, who served President Bill Clinton as the Chairman of the U.S. Presidential Committee on HIV/AIDS. In this capacity, Dr. Herman, Mr. Dellums and Congresswoman Barbara Lee (the founding co-chair of the Congressional HIV/AIDS Caucus) developed the successful congressional legislation for the "AIDS Marshall Plan for Africa" which formed the basis of the President's Emergency Plan for AIDS Relief (PEPFAR). For his work in HIV/AIDS, Dr. Herman received the 'Heroes in Medicine' award from the International Association of Physicians in AIDS Care.
Dr. Herman will report directly to the President & CEO, Mr. Raymond C. Dabney to assist him in tracking and monitoring the multiple international drug development programs the company has underway. Because of Dr. Herman's expertise in international healthcare management and physician and health professional continuing education he will be key to assist Mr. Dabney on a daily basis to report to the public the Company's scientific progress and accomplishments.
From a pr. in March of 2015 :
Dr. Herman, while serving as a project officer and program director at the National Institutes of Health (NIH) designed the basis for a nationwide $160 million infant mortality reduction program and was the co-director of joint projects between the NIH and the Centers for Disease Control and Prevention (CDC). His work as the scientific director of a $25 million NIH Infant Mortality Reduction research program defined much of the basis for much of the current community-based maternal and child health public health work designed to provide a healthy start for families. For his work in maternal and child health Dr. Herman received the National Institutes Award of Merit. In addition to his work on maternal and child health, Dr. Herman was a member of the World Mental Health Survey team and helped design and execute the South African Stress and Health Study, the largest mental health survey in Africa.
He was the founding Dean of the Republic of South Africa's National School of Public Health. Dr. Herman also served as scientific advisor to then deputy-president (and now president) of the Republic of South Africa, Jacob Zuma and the South African Minister of Defense in the design and execution of a substantial HIV/AIDS treatment program for the South African National Defense Force. Dr. Herman and Mr. Dellums secured $100 million from Bristol-Myers Squibb. These funds were used to develop the 'Secure the Future' project, a research and scientific development program in southern Africa. Dr. Herman served as a Principal Investigator and on the Scientific Advisory Board of 'Secure the Future'.
Dr. Herman was also the Advisor to Ronald V. Dellums, who served President Bill Clinton as the Chairman of the U.S. Presidential Committee on HIV/AIDS. In this capacity, Dr. Herman, Mr. Dellums and Congresswoman Barbara Lee (the founding co-chair of the Congressional HIV/AIDS Caucus) developed the successful congressional legislation for the "AIDS Marshall Plan for Africa" which formed the basis of the President's Emergency Plan for AIDS Relief (PEPFAR). For his work in HIV/AIDS, Dr. Herman received the 'Heroes in Medicine' award from the International Association of Physicians in AIDS Care.
Dr. Herman will report directly to the President & CEO, Mr. Raymond C. Dabney to assist him in tracking and monitoring the multiple international drug development programs the company has underway. Because of Dr. Herman's expertise in international healthcare management and physician and health professional continuing education he will be key to assist Mr. Dabney on a daily basis to report to the public the Company's scientific progress and accomplishments.
(0)
(0)Cannabis Science Inc (CBIS) Stock Research Links
In times when you feel low self esteem, disappointment and perhaps even depression.......keep in mind that it may simply be the result of the fact that you are surrounded by ass holes. GLTA